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Background: The role of polymorphonuclear neutrophils in pulmonary host defense is well recognized. The in-
ﬂuence of a pre-existing inﬂammation driven by neutrophils (neutrophilic inﬂammation) on the airway epi-
thelial response toward pro-inﬂammatory exogenous triggers, however, is still poorly addressed. Therefore,
the aim of the present study is to investigate the effect of neutrophils on lipopolysaccharide (LPS)-induced
pro-inﬂammatory signaling in lung epithelial cells. Additionally, underlying signaling pathways are examined.
Methods: Human bronchial epithelial cells (BEAS-2B) were co-incubated with human peripheral blood neu-
trophils or bone-marrow derived neutrophils from either C57BL/6J wild type or nicotinamide adenine dinu-
cleotide phosphate (NADPH)-oxidase deﬁcient (p47phox−/−) mice. Upon stimulation with LPS, interleukin
(IL)-8 production and reactive oxygen species (ROS) generation were measured. Additionally, activation
of the extracellular signal-regulated kinases (ERK) 1/2 and nuclear factor (NF)-κB signaling pathways was
analyzed.
Results: Our studies show that the presence of neutrophils synergistically increases LPS-induced IL-8 and ROS
production by BEAS-2B cells without inducing cytotoxicity. The observed IL-8 response to endotoxin in-
creases in proportion to time, LPS-concentration and the number of neutrophils present. Moreover, this syn-
ergistic IL-8 production strongly correlated with the chemotactic properties of the co-incubations and
signiﬁcantly depended on a functional neutrophilic NADPH oxidase. The presence of neutrophils also aug-
ments LPS-induced phosphorylation of ERK1/2 and IκBα as well as NF-κB RelA DNA binding activity in
BEAS-2B cells.
Conclusions: Our results indicate that the pro-inﬂammatory effects of LPS toward lung epithelial cells are
ampliﬁed during a pre-existing neutrophilic inﬂammation. These ﬁndings support the concept that patients
suffering from pulmonary neutrophilic inﬂammation are more susceptible toward exogenous pro-
inﬂammatory triggers.© 2012 Elsevier B.V. All rights reserved.1. Introduction
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rights reserved.defense against these potential threats, the airway epithelial cells are
not only providing a physical barrier butwill also enhance the clearance
of these invadingmicro-organisms by stimulating the expression of var-
ious inﬂammatory mediators including mucus proteins and cytokines
[1,2]. In general, NOX enzymes can produce large amounts of ROS,
mainly superoxide anion radical and H2O2, upon stimulation with vari-
ous bacterial and environmental triggers including endotoxins and am-
bient particulate matter [2]. Classically, the phagocytic NOX has been
regarded as the main player of systemic innate immune responses [3].
Upon intrusion of microbial pathogens, neutrophils will be recruited
from the circulation to attack and neutralize these pathogens by pro-
ducing ROS via their NOX-driven respiratory burst. Alternatively, it
has become appreciated that the lung also comprises other NOXs capa-
ble of producing ROS. Indeed, it is shown that the NADPH oxidase ho-
mologs DUOX1/2 are the primary sources of pulmonary epithelial
production of H2O2 [4,5]. Being a substrate for lactoperoxidase and
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hypothiocyanous acid and hypochlorous acid, which both possess
strong bactericidal capacities [6–9]. Other NOX enzymes displaying
pulmonary expression include NOX2 and, to a lesser extent, NOX4,
although the expression of these enzymes largely resides in non-
epithelial cells present in the lung including respectively phagocytic
inﬂammatory cells (neutrophils and macrophages) and ﬁbroblasts
[2,4,10,11]. Interestingly, it has recently been suggested that ROS pro-
duced by NOX4 play a role in tissue repair functions and pulmonary
ﬁbrogenesis as this homolog is upregulated in lungs of mice subjected
to noninfectious injury aswell as in lungs of pulmonary ﬁbrosis patients
[12].
An important player in the respiratory epithelial defense, which is
also highly ROS-inducible, is the chemokine IL-8/CXCL8. Although IL-
8 displays various inﬂammatory effects, including induction of ROS
production and modulation of histamine release, its key activity is
the chemotaxis of PMN toward infectious sites [13,14]. Expression
of the IL-8 gene is regulated by several pathways, as can be deducted
from the presence of binding sequences for various transcription fac-
tors, including NF-κB and AP-1, on its promoter region [15,16]. The
transcription factor AP-1 is composed of members of the jun and fos
DNA-binding protein families [15,17]. The abundance and activity of
AP-1 relies on the phosphorylation of both the jun and fos proteins
[18] by respectively c-Jun NH2-terminal kinases and ERKs. Upon acti-
vation, ERKs translocate into the nucleus and phosphorylate fos pro-
teins. For c-fos, fosB and fra1 it has already been shown that this
phosphorylation occurs on serine and/or threonine residues in the
COOH-terminal domain [19]. The transcription factor NF-κB is present
in the cytoplasm as an inactive complex, typically existing as a dimer
of the RelA and p50 subunits that is bound to the inhibitory protein
IκB [20,21]. The classical NF-κB activation involves phosphorylation
of the cytosolic inhibitor protein IκBα at the serine residues 32 and
36 by the IKK enzyme complex, leading to the protein's rapid
ubiquitination at lysines 21 and 22 and subsequent annihilation by
the 26S proteosome [20]. Consequently, the dissociated NF-κB
dimer is released and translocates to the nucleus.
Upon secretion of IL-8 by the airway epithelium, large amounts
of PMN will migrate into the lung lumen where they become acti-
vated and undergo a respiratory burst [22]. This burst, initiated by
NOX2, is a self-destructing process characterized by an extensive
ROS production. In resting cells, NOX2 is a fully inactive enzyme
that exists as a cytosolic complex, containing p47phox, p67phox and
p40phox [3,23]. On activation, its regulatory subunit p47phox becomes
phosphorylated and translocates to the membrane where it will bind
to its transmembrane cytochrome unit comprising both NOX2 and
the closely associated p22phox [2,3,23]. The distinct movement of
GTP-binding protein Rac to the membrane enables the combination
of all required regulatory units to form an active enzyme, capable
of transferring electrons from NADPH via a bound ﬂavin adenine nu-
cleotide to molecular oxygen to form superoxide anion radical
[3,23,24].
Due to their biological activity, stimulated neutrophils may rep-
resent a double-edged sword for pulmonary homeostasis. On the
one hand, the appropriate recruitment of neutrophils toward the
infected part of the airway results in killing the invading micro-
organisms and thus preserving the homeostasis. On the other
hand, those same activated neutrophils also possess the ability to
seriously damage host tissue. For example, activated neutrophils
have been shown to induce oxidative DNA-lesions [25,26] and to
inhibit DNA nucleotide excision repair [27] in pulmonary epithelial
cells. Moreover, excessive neutrophil inﬂux and/or incomplete apo-
ptosis of activated neutrophils may result in disproportionate ROS
production and prolonged inﬂammation. Indeed, neutrophil dys-
regulation has been associated with various pulmonary inﬂammato-
ry diseases including asthma, adult respiratory distress syndrome
and chronic obstructive pulmonary disease [28,29]. However, theinﬂuence of a pre-existing pool of neutrophils, resulting from either
a yet-to-be resolved inﬂammation or a chronic lung condition, on
the airway epithelial response toward noxious stimuli is not
known. Therefore, the aim of the current study is to investigate
the effect of neutrophils on LPS-induced pro-inﬂammatory signaling
in lung epithelial cells.
2. Materials and methods
2.1. Chemicals
LPS from Escherichia coli (0.26:B6), PMA, transferrin, insulin, dexa-
methasone, bovine pituitary extract, trypsin, 4-aminobenzoic acid
hydrazide (4-ABAH) and luminol (3-aminophthalhydrazide) were
purchased from Sigma (St. Louis, MO). Hoechst 3342, penicillin,
streptomycin, HBSS, DMEM/Ham's F12 (1:1), trizol and BSA were
obtained from Gibco Invitrogen (Paisley, UK). Epidermal growth fac-
tor was acquired from Biomol (Hamburg, Germany) while CPH was
purchased from L-Optik (Berlin, Germany). The RNeasy mini kit was
provided by Qiagen (Germany). The iScript cDNA Synthesis kit and
SYBR© Green Supermix were supplied by Biorad (Germany). TLR-4,
IL-8 and β-actin primers were ordered at Euroﬁns MWG Operon
(Germany) with the following sequences: β-actin forward: 5′-CCC
CAG GCA CCA GGG CGT GAT-3′; β-actin reverse: 5′-GGT CAT CTT
CTC GCG GTT GGC CTT GGG GT-3′; TLR-4 forward 5′-TGC ATG GAG
CTG AAT TTC TAC-3′; TLR-4 reverse: 5′-TGA GCC ACA TTA AGT TCT
TTC-3′. Cholera toxin was generously provided by Dr J. de Jonge
(Maastricht University, the Netherlands). All other chemicals were
of analytical grade.
2.2. Cytotoxicity
Cytotoxicity was determined by the lactate dehydrogenase (LDH)
assay as a marker of plasma membrane damage using a colorimetric
kit (Roche, Switzerland) according to the manufacturer's instructions.
2.3. Isolation of human and murine PMN
The fresh isolation of human PMN, using blood of 3 healthy male
and 3 healthy female volunteers (ages 30–45), was performed as de-
scribed previously with minor modiﬁcations [26]. In short, blood
was diluted with cold HBSS (1:1) after which gradient centrifugation
was used to remove the lymphocytes. The remaining lowest layer
containing PMN and erythrocytes was then suspended in cold lysis
buffer to lyse the erythrocytes. The remaining pellet containing
PMN only was suspended in HBSS and counted using a Bürker cham-
ber. Viability was tested using Trypan Blue dye exclusion (0.4%).
Keeping all solutions and PMN on ice all the time to prevent prema-
ture activation, this isolation method consistently yielded PMN with
a viability >95%.
For the fresh isolation of murine PMN, the femurs and tibias of
speciﬁc pathogen-free C57BL/6J (WT) and p47phox−/− knockout
(KO) mice were used [30]. Animals were obtained from Taconic
(Lille Skensved, Denmark) and had ad libitum access to food and
water containing antibiotics (800 mg sulfamethoxazol and 160 mg
trimethoprim per liter). Upon sacriﬁcing the animals using a phe-
ntobarbital overdose, bone-marrow derived PMN were obtained
according to the method originally described by Boxio et al. [31].
Upon harvesting the PMN fraction using a three-layer Percoll gradi-
ent, the similar procedure as for the human PMN was used with
the exception that HBSS was replaced by HBSS containing 0.5%
BSA. Consequently, this isolation method, combined with cooling
all the solutions and PMN again, also resulted in a constant and vi-
able (>95%) yield. No remarkable differences regarding reactivity
were observed between PMN isolated from male and female
volunteers.
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The immortalized human bronchial epithelial cell line BEAS-2B was
obtained from the American Type Culture Collection and cultured in
DMEM/Ham's F1 medium (1:1) supplemented with insulin (5 μg/ml),
transferrin (5 μg/ml), epidermal growth factor (10 ng/ml), dexametha-
sone (0.1 μM), cholera toxin (10 ng/ml), bovine pituitary extract (15 μg/
ml) and BSA (0.5 mg/ml) at 37 °C and 5% CO2. For the various experi-
ments, cells were grown to conﬂuence in either 60 mm dishes
(signaling and RT-PCR), 24 well plates (cytotoxicity and IL-8 produc-
tion) or 96well plates (chemiluminescence) and starved for 24 h by re-
ducing the concentrations of supplement to 10%. Subsequently, cells
received fresh starvation medium for another hour after which they
were stimulated with LPS (10 or 100 μg/ml). When indicated, cells
were (pre-)treated with the appropriate inhibitors. For the general co-
incubations, BEAS-2B cells were incubated in the presence or absence
of an equal PMN number, but in speciﬁc experiments 3 times lower
and higher PMN numbers were also applied. When indicated, PMN
inactivated by heat (46 °C for 7.5 min) were used. After co-incubation,
PMN were washed off using cold HBSS as described previously [26].
Cells or conditioned media were collected as indicated in the Results
section.
2.5. Measurement of IL-8 protein levels
IL-8 protein levels in the conditioned media were quantiﬁed after 4
and 24 h of stimulation using an IL-8 ELISA kit (CLB/Sanquin, The Nether-
lands) based on appropriate and validated sets ofmonoclonal antibodies.
The assaywas performed as described in themanufacturer's instructions.
2.6. Chemotaxis
Upon fresh isolation as described above, human PMN were sta-
ined with Hoechst 3342 (12 μg/ml) for 30 min at 37 °C followed by
two washing steps with cold HBSS. To measure the chemotactic
properties of the conditioned media after 24 hour stimulation with
LPS, the samples were transferred to the lower wells of a 96-
transwell plate (Costar, pore size 3 μm). Next, the stained PMN
were carefully added to the upper wells of the plate in a ﬁnal con-
centration of 300,000 cells/ml. Following 90 minute incubation at
37 °C, the migration of the PMN to the lower wells was measured
using ﬂuorescence (excitation wavelength 350 nm, emission wave-
length 460 nm).
2.7. Western blot analysis
To examine the phosphorylation of ERK1/2 and IκBα, cells were
stimulated with LPS for 15 min, washed twice with cold PBS and col-
lected in 100 μl lysis buffer (1% NO-40, 0.5% sodium deoxycholate,
0.1% SDS in PBS) containing freshly added protease inhibitor cocktail
(Roche, Prenzberg, Germany; 1 tablet/12 ml buffer). After incubation
for 15 min on ice, cell lysates were collected by scraping and
centrifuging (16,000 g, 5 min, 4 °C) to remove cell debris. Protein con-
centrations were determined by BioRad-Assay (according to the
Bradford method) and samples were analyzed by Western blotting.
To this extent, samples were separated at equal protein concentra-
tions (10–15 g) by SDS-PAGE on 10% gels and transferred to nitrocel-
lulose membranes. Membranes were blocked to prevent non-speciﬁc
protein binding and incubated (24 h, 4 °C) with speciﬁc polyclonal
antibodies against phosphorylated ERK1/2 (1:1000), total ERK1/2
(1:1000), phosphorylated IκBα (1:2000) or tubulin (1:5000). Visual-
ization occurred using a secondary anti-mouse igG whole protein
horseradish-conjugated antibody (1:1000 for phosphorylated and
total ERK/12; 1:2000 for phosphorylated IκBα and 1:5000 for tubu-
lin) and enhanced chemiluminescence (Pierce). Quantiﬁcation was
performed using the software Quantity One (Bio-Rad).2.8. NFκB RelA binding activity assay
To investigate the DNA binding activity of the NFκB RelA subunit,
an ELISA based DNA binding activity assay was performed using the
nuclear extracts of the BEAS-2B cells from the various incubations.
Nuclear fractions were prepared with a commercially available nucle-
ar extraction kit (Active Motif, Belgium). The assay was performed
using 20 μg of nuclear extract according to the manufacturer's recom-
mendations. As a positive control, 2.5 μg Jurkat cell nuclear extract
was used as supplied in the kit (cat no. 36014). Absorbance was
read at 450 nm, while 650 nm was used as the reference wavelength.
2.9. ROS formation measurements by luminescence and EPR
For the measurement of ROS by luminol-enhanced chemilumines-
cence, BEAS-2B cells were seeded in a white Maxisorp 96-well plate
(Nunc, Germany) and grown to conﬂuence. Upon starvation and wash-
ing the cells twice with warm PBS, the cells were stimulated with LPS
(100 μg/ml) or the known NOX2 activator PMA in the presence or ab-
sence of PMN. Next, the H2O2-sensitive probe luminol (5*10
−4 M)
was added and chemiluminescence was recorded for 60 min at 37 °C
using a luminometer (Multi-Bioluminat, Berthold, Germany).
ROS production by murine PMN was analyzed with EPR spectrosco-
py using the spin probe CPH that is highly sensitive for O2•−−. PMN
were suspended in cold HBSS-BSA (5*10
5 cells/ml) and, upon addition
of CPH (0.5 mM), stimulated with PMA (50 ng/ml) or LPS (10 μg/ml)
for 120 min at 37 °C. ROS generation was evaluated using a MiniScope
MS200 Spectrometer (Magnettech, Berlin, Germany) with the following
instrumental settings: RT; magnetic ﬁeld 3360 G; sweep width 100 G;
scan time 60 s; number of scans 1 and modulation amplitude 1800 G.
Data shown include a representative example out of three independent
experiments, comprising the peak triplet characteristic for CPH.
2.10. Quantitative RT-PCR
To conﬁrm the translation of TLR4 in the cells used, conﬂuent
BEAS-2B layers were treated with LPS for 24 h, scraped and homoge-
nized in Trizol. RNA was extracted using the RNeasy mini kit
according to the instructions provided by the manufacturer. The qual-
ity and quantity of the obtained RNAwere assessed using spectropho-
tometrical analysis at wave lengths of 230, 260, 280, and 320 nm. For
isolated RNA, a ratio of at least 1.7 for values obtained at 280 nm and
260 nm was considered acceptable.
Next, a 0.5 μg cDNA sample was synthesized using the iScript
cDNA Synthesis kit. To this end, all cDNA samples were diluted 15
times in RNase-free water prior to qRT-PCR. Brieﬂy, 2.5 μl of 0.3 μM
forward and 2.5 μl 0.3 μM reverse primer was added to 2.5 μl water,
5 μl diluted cDNA and 12.5 μl SYBR© Green Supermix (Biorad) in
each well of a 96 well plate to generate 25 μl of reaction mixture. A
MyiQ Single Color Real Time PCR Detection System (BioRad) was
used to perform qRT-PCR. The denaturation step, that took place at
95 °C for 3 min, was followed by 40 cycles at 95 °C (15 s) and 60 °C
(45 s). An additional step involving the generation of a melt curve
(60–95 °C) was performed to ensure that the correct product was
ampliﬁed and quantiﬁed. The results were analyzed using the MyiQ
Software system (BioRad) and expressed according to the 2-ΔΔCt
method as relative gene expressions (fold increase) of representative
control samples, normalized for the housekeeping gene β-actin.
2.11. Data expression and statistical analysis
With exception of the signaling and RT-PCR experiments that
were performed in single dishes of three independent experiments,
all incubations were performed in duplicate wells in each of at least
three independent experiments. Data are expressed as median,
range and inter-quartile ranges unless otherwise mentioned.
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Fig. 1. LPS dose-dependently induces IL-8 production in human PMN, BEAS-2B and the combination of both cell-types. Upon starvation, BEAS-2B cell monolayers were stimulated
with LPS (10 or 100 μg/ml) for either 4 (panels A and C) or 24 (panels B and D) hours in the absence or presence of various numbers of freshly-isolated human PMN. Afterward, the
IL-8 secretion in the medium was measured. Additionally, the IL-8 production by LPS-stimulated PMN in the absence of BEAS-2B cells was determined. Moreover, the constitutive
and LPS-induced gene expressions of TLR4 was analyzed after 24 h (panel E). Finally, cytotoxicity of the different LPS treatments on BEAS-2B cells was evaluated for 4 (panel F) and
24 h (panel G). Except for panel E, data are expressed as median, range and inter-quartile ranges of either n=6 with 3 different PMN donors (panels A, B, F, G and H) or n=4 with 2
different PMN donors (panels C and D). Data in panel E are expressed as average±S.E.M. of n=3. a=Pb0.05 compared to the corresponding incubation with PMN only; b=Pb0.05
compared to the corresponding incubation without LPS; c=Pb0.05 compared to the corresponding incubation with BEAS-2B; d=Pb0.05 compared to the corresponding incuba-
tion with 10 μg/ml LPS; and e=Pb0.05 compared to the corresponding incubation with ratio 3:1.
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Fig. 2. LPS dose-dependently provokes the release of chemo-attractants by BEAS-2B
cells in relation to both the number of PMN present and the IL-8 produced. Upon 4
(panel A) and 24 (panel B) hour stimulation with LPS (10 or 100 μg/ml), the superna-
tants of BEAS-2B cells co-incubated with various numbers of PMN were added to the
lower wells of 96-transwell plate (pore size of 3 μm). Freshly-isolated human PMN
were stained with Hoechst 33342 (12 μg/ml) and then added to the upper wells of
the plate in a ﬁnal concentration of 300,000 cells/well. Following 90 minute incubation
at 37 °C, the migration of the PMN to the lower wells was measured using ﬂuorescence
(excitation wavelength 350 nm, emission wavelength 460 nm). Data are expressed as
median, range and inter-quartile ranges for all co-incubations (panels A and B; n=4
with 2 different PMN donors) and correlated with the IL-8 production for the co-
incubation with equal amounts of BEAS-2B cells and PMN (panel C). a=Pb0.05 com-
pared to the corresponding incubation with ratio 1:0 and b=Pb0.05 compared to the
corresponding incubation with ratio 3:1.
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Whitney U test (SPSS 15.0). Differences were considered signiﬁcant
if Pb0.05.
3. Results
3.1. LPS induces synergistic IL-8 production and chemoattractant release
in a co-incubation of BEAS-2B cells and PMN
As shown in Fig. 1A and B, LPS induced increased IL-8 production
in human BEAS-2B epithelial cells and PMN after 4 and 24 h, respec-
tively. Only the highest LPS concentration did not induce any IL-8 pro-
duction in the PMN alone after 24 h. This ﬁnding is probably due to
toxicity, leading to quick and complete bursting, as a result of the
long exposure to such a high dose (Fig. 1G). In the BEAS-2B cells,
this LPS effect appeared to be clearly dose-dependent at both time-
points. Our ﬁndings are in line with previous studies showing that
both cell types will produce IL-8 upon stimulation with the TLR-4 li-
gand LPS [14,32–34]. Indeed, in accordance with other studies[32,35,36], our RT-PCR studies conﬁrmed the translation of this re-
ceptor in the BEAS-2B cells (Fig. 1E). Moreover, co-incubating the ep-
ithelial cells with human PMN did not result in any additional
cytotoxicity in the BEAS-2B (Fig. 1F and G).
Next, the effect of LPS on the IL-8 production by a co-incubation of
both BEAS-2B cells and PMN in a ratio of 1:1 was examined. In co-
incubations of both cell types in a 1:1 ratio, LPS caused an IL-8 produc-
tion that was far higher than the sum of these cytokine levels pro-
duced by the two separate cell types (Fig. 1A and B). Again, this
LPS-effect was signiﬁcantly dose-dependent at both time-points.
Moreover, after 24 h without any external stimulus, this co-
incubation also resulted in an enhanced IL-8 production compared
to the corresponding incubation with only PMN (Fig. 1B).
To explore the inﬂuence of PMN number on this observed syner-
gistic IL-8 production, the co-incubations have also been performed
in a 3:1 and 1:3 ratio. As depicted in Fig. 1, the LPS-induced IL-8 pro-
duction by BEAS-2B cells increases proportionally to the number of
PMN present after both 4 (panel C) and 24 (panel D) hours.
Based on the knowledge that IL-8 is an effective chemotactic factor
for neutrophils [37], the migration of human neutrophils toward su-
pernatants of BEAS-2B cells treated with LPS in the absence or pres-
ence of an equal number of PMN has been examined. Fig. 2A and B
show that the supernatants of LPS-treated BEAS-2B cells provoked
signiﬁcant migration of PMN in a dose-dependent manner. Interest-
ingly, in analogy with the IL-8 production, this chemotactic effect of
the BEAS-2B supernatants was dependent on time, LPS concentration
and the number of neutrophils present. Moreover, the chemotaxis in-
duced by the supernatants of BEAS-2B cells treated in the presence of
an equal number of PMN displayed a strong and signiﬁcant correla-
tion with the corresponding IL-8 production of these co-incubations
(Fig. 2C).
3.2. The presence of human PMNaugments the LPS-induced phosphorylation
of ERK1/2 and IκBα as well as the NFκB RelA DNA binding activity in
BEAS-2B cells
It has previously been demonstrated that LPS-induced pulmonary
IL-8 production is associated with increased activation of ERK1/2 and
NF-κB [1,14,38,39]. Consequently, the involvement of both signaling
molecules in the synergistic LPS-induced IL-8 production observed
in our co-incubation was examined.
Western blot analysis demonstrated a signiﬁcant activation of
ERK1/2 by both LPS concentrations (Fig. 3A). The presence of an
equal number of human PMN further enhanced this LPS-induced
ERK1/2 activation, although this enhancement was only statistically
signiﬁcant when cells were stimulated with the lower LPS concentra-
tion of 10 μg/ml. Similarly, both LPS concentrations signiﬁcantly in-
duced the phosphorylation of the NF-κB inhibitory part IκBα, a
process that leads to the activation of this transcription factor
(Fig. 3B). Indeed, LPS was also capable of signiﬁcantly increasing the
DNA binding activity of the NF-κB RelA subunit (Fig. 3C). In accor-
dance with the ERK1/2 ﬁndings, the IκBα phosphorylation was also
more pronounced when the BEAS-2B cells were stimulated in the
presence of PMN, although statistical signiﬁcance of this effect was
only observed when 10 μg/ml LPS was used. Additionally, the LPS-
induced DNA binding activity of the NF-κB RelA subunit was signiﬁ-
cantly increased in the presence of PMN when compared to the con-
trol incubation without LPS. Interestingly, just the presence of PMN
without additional stimulation with LPS also induced a signiﬁcant
phosphorylation of both transcription factors as well as an increased
DNA binding activity of NF-κB RelA in the BEAS-2B. This ﬁnding is
in accordance with the observation that PMN without additional
stimulation already display a minor burst in the control experiments
due to the incubation temperature (37 °C).
Additionally, we have monitored the activity of human PMN over
time to check whether these cells could also affect the ERK1/2 and
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from Fig. 3D, the activity of human PMN was completely and perma-
nently abolished after 30 min. Consequently, it can be stated that no
second burst of activation will occur within our in vitro co-
incubation system.
3.3. LPS-mediated ROS production is synergistically increased in
co-incubations of BEAS-2B and human PMN
Upon showing ERK1/2 and NF-κB activation in the observed syner-
gistic IL-8 production by the co-incubation, the possible role of ROS
herein was assessed using luminol-enhanced chemiluminescence. In
contrast to PMN, BEAS-2B cells alone did not produce signiﬁcantamounts of ROS upon treatment with LPS. In the co-incubations, LPS
induced an ROS production that by far exceeded the sum of the ROS
produced by the two cell types separately (Fig. 4).
3.4. Neutrophilic NADPH-oxidase plays a crucial role in ROS production
by the co-incubation of BEAS-2B and PMN
In view of the observed synergistic ROS production in the co-
incubations, we evaluated the role of the neutrophilic NADPH oxidase
complex herein using two independent approaches. First, the role of
NADPH oxidase in human neutrophils was assessed by using heat inac-
tivation to temporarily inactivate enzyme function. Second,we replaced
the human neutrophils by neutrophils isolated from bone marrow of
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[30]. Using either approach, a signiﬁcantly reduced ROS production by
PMN upon stimulation with LPS or the positive control, the known
NOX2 activator PMA, was observed (Fig. 5A and 6). Next, the role of
the neutrophil NADPH oxidase on the synergistic ROS production ob-
served in the co-incubation of BEAS-2B cells and PMN was evaluated
by treating BEAS-2B cells with LPS (Fig. 5B) in the presence of normal
or heat-inactivated human PMN. In accordance with our expectations,
the synergistic ROS production previously observed when both cell-
types were simultaneously stimulated with LPS was signiﬁcantly an-
nulled when the PMN were ﬁrst heat inactivated.
3.5. Synergistic IL-8 production by a co-incubation of BEAS-2B cells and
murine PMN is largely neutrophil NADPH oxidase-dependent
After demonstrating an important role for an intact NOX2 in the
synergistic ROS production by BEAS-2B cells and an equal number
of PMN, the involvement of neutrophilic NADPH oxidase in the ob-
served synergistic IL-8 production was investigated. To this extent,
we used neutrophils from WT and p47phox−/− mice as heat inactiva-
tion did not last longer than 1 h (data not shown).
Upon LPS treatment for either 4 (Fig. 7A) or 24 h (Fig. 7B), a signif-
icantly increased IL-8 production was observed in co-incubations of
BEAS-2B and an equal number of WT PMN in comparison to the
corresponding BEAS-2B mono-cultures. No immune-reactivity for
human IL-8 was detected in supernatants from control and LPS-
treated murine WT neutrophils, conﬁrming that the enhanced IL-
8 production in the co-incubations originates from the BEAS-2B
cells. In LPS-treated co-incubations containing p47phox−/− PMN, IL-
8 levels were signiﬁcantly lower than those measured in the
corresponding incubations with WT PMN, except for the cultures
that were treated with 100 μg/ml LPS for only 4 h. Moreover, with
the exception of the 4 h treatment with 10 μg/ml, no statistically
signiﬁcant difference was observed between the LPS treated co-
incubations that contained p47phox−/− PMN and the corresponding
BEAS-2B mono-cultures. Notably, after 4 h the IL-8 production
induced by the highest LPS concentration (100 μg/ml) was signiﬁcantly
lower in all incubations compared to the corresponding incubations
with the lower LPS concentration (10 μg/ml).Interestingly, the importance of NADPH oxidase within the ob-
served synergism was further underlined by the ﬁnding that inhibi-
tion of myeloperoxidase (MPO), another important ROS producing
neutrophilic enzyme, did not inﬂuence the LPS-induced IL-8 produc-
tion in the co-incubation (Fig. 7C).
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Various lung diseases, including chronic obstructive pulmonary
disease and cystic ﬁbrosis, are characterized by an increased number
of neutrophils [40,41]. It has been discussed that patients suffering
from such diseases are more susceptible toward exogenous pro-
inﬂammatory triggers. In order to explore possible mechanisms un-
derlying this susceptibility issue, we have investigated the inﬂuence
of neutrophils on LPS-induced pro-inﬂammatory signaling in BEAS-
2B cells. To this end, we have applied an in vitro model based on
our previous work [26], in which BEAS-2B cells and neutrophils
were co-incubated to mimic possible crosstalk between these struc-
tural and inﬂammatory cell types. In LPS treated co-incubations a
marked synergism in ROS production, release of IL-8 and neutrophil
chemotactic activity could be observed. Moreover, LPS-induced phos-
phorylation of ERK1/2 and IκBα as well as NFκB RelA DNA binding ac-
tivity was signiﬁcantly augmented in the presence of neutrophils.
Blocking the neutrophilic NADPH oxidase activity, either temporarily
by heat inactivation or indeﬁnite by applying the p47phox−/− knock-
out mouse model, resulted in the annulment of the observed syner-
gistic ROS production and IL8-release. The results of these studies
demonstrate that the effects of LPS toward lung epithelial cells are
ampliﬁed in the presence of neutrophils.
It is known that LPS exerts its effects in epithelial cells by binding
to TLR 4, a receptor that is indeed also functionally active in our BEAS-
2B cells [32,36,42]. By activating TLR4, LPS induces the transcription
of various pro-inﬂammatory cyto- and chemokines including IL-8 but also GM-CSF and MIP-3α [32,35]. Previously, we have shown
that in human bronchial epithelial cells, the general response mecha-
nism to LPS involves extracellular ATP release leading to the activa-
tion of epithelial DUOX1. Subsequently, this DUOX1-dependent
H2O2 production was shown to induce a pro-inﬂammatory cascade
including the activation of ERK1/2 and NF-κB and the production of
IL-8 [1]. These previous observations are in concordance with our
present ﬁndings, showing LPS-mediated TLR4 activation of a pro-
inﬂammatory cascade in the BEAS-2B cells involving ROS production
and resulting in increased IL-8 production.
In the presence of neutrophils, BEAS-2B cells showed a markedly
enhanced LPS-triggered activation of ERK1/2 and NF-κB, accompa-
nied by a synergistic IL-8 release. We postulate that these effects are
a direct consequence of the close contact between the two cell
types, leading to the concurrently observed synergistic ROS genera-
tion in this co-incubation, crucially driven by the neutrophilic
NADPH oxidase NOX2 (Fig. 8). The experimental set-up comprising
a co-culture model does not only closely resemble the in vivo situa-
tion in the lung, but has also been shown to be essential to induce
damage to lung epithelial cells by neutrophilic ROS production. In-
deed, we have previously shown that averting this close contact by
using only supernatants or inserts abolishes the ROS diffusion from
the neutrophils to the epithelial cells needed to induce damage in
the latter [26,43].
The NOX2 enzyme complex of activated neutrophils is well known
to produce large amounts of superoxide anion radical [44], which can
dismutate into the more stable, membrane-diffusible ERK1/2- and
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lung ﬁbroblasts indicate that superoxide itself is also capable of enter-
ing cells and activating ERK1/2 [49], hence providing an additional or
alternative mode of action for ROS to affect ERK1/2 and NF-κBsignaling (Fig. 8). Since LPS was less potent than PMA in inducing a
respiratory burst in PMN, we suggest that the observed LPS-
mediated synergistic ROS formation also involves active participation
of the epithelial cells via a yet-to-be unraveled mechanism. Addition-
ally, some residual IL-8 production could be observed in the co-
incubations containing PMN with an inactive NOX2. This points to
other neutrophil-derived components involved in the observed syn-
ergistic ROS-production, although their contribution seems to be
limited.
A major outcome of our study was the pronounced PMN-
dependent production of chemo-attractive IL-8 by the BEAS-2B
cells. Indeed, IL-8 is considered to be the major neutrophil chemotac-
tic factor in the lung [50,51] and therefore our ﬁndings indicate that
the presence of a pulmonary neutrophil pool may facilitate the re-
cruitment of additional neutrophils upon exposure to LPS. Whether
IL-8 is also involved in the direct activation of neutrophils in our co-
incubation, and may thus represent a pro-inﬂammatory ampliﬁcation
loop, remains open for debate. On the one hand, IL8 has been shown
to prime and/or activate NOX2 [52,53]. On the other hand, the syner-
gistic effects were also observed in co-incubations containing murine
neutrophils, even though phagocytes from this species are poorly ac-
tivated by human IL-8 as produced by the BEAS-2B cells.
In our present studies, neutrophils derived from the bone mar-
row of p47phox−/− mice were applied to explore the speciﬁc role
of NOX2 in amplifying epithelial pro-inﬂammatory signaling as this
enzyme is nowadays considered to be relevant in various diseases
[54]. Our approach provides a model that addresses the role of
NOX2 in neutrophilic inﬂammation, a situation known to occur in
chronic pulmonary diseases including chronic obstructive pulmo-
nary disease and cystic ﬁbrosis. However, NOX2 knockout mice
were initially developed to study its role in host defense as it is
known that people lacking this enzyme develop chronic granuloma-
tous disease, a condition characterized by increased infections and
granuloma formation [55]. As such, Zhang et al. have recently
shown that LPS induces a stronger inﬂammatory response in NOX2
deﬁcient mice than in the WT animals [56]. At ﬁrst sight, this ﬁnding
seems to be in contrast to our ﬁndings, but it is important to consid-
er some essential differences in the study objective and design.
Zhang et al. have administered LPS intraperitoneally to systemically
study endotoxin-induced inﬂammation under impaired defense condi-
tions, whereas we studied this process in neutrophil-loaded conditions
that mimic a primed inﬂammatory lung found in patients suffering
from chronic pulmonary diseases. Considering the differences in out-
come, it would be interesting to determine the pulmonary pro-
inﬂammatory effects of LPS inwild type andNOX2 impairedmice already
subjected to neutrophil inﬁltration, e.g. by using repeated LPS instilla-
tions. In such way, also the impact of chronic or recurring exposure to
other noxae, including particulate air pollution, on the course of chronic
neutrophilic lung diseases could be assessed.
As it holds true for many in vitro models, cell culture studies have
some intrinsic limitations and therefore data from these types of ex-
periments should be interpreted with care. For instance, our model
does not take into account potential effects of other inﬂammatory
or structural cell types that are thought to be relevant in pulmonary
inﬂammation such as resident alveolar macrophages and the pulmo-
nary endothelium. Perhaps the most important deﬁcit in our current
in vitro co-incubation model is that it does not include physiological
mechanisms implicated in the resolution of neutrophilic inﬂamma-
tion. The speciﬁc recognition and subsequent pulmonary clearance
of apoptotic neutrophils is recognized as an important anti-
inﬂammatory feedback mechanism. Such regulatory loops are
thought to be comprised in chronic inﬂammatory lung diseases and
therefore considered to actually contribute to their pathogenesis. In-
deed, current studies are undertaken to pharmacologically target
these apoptosis-driven clearance pathways [57]. Another possible
discrepancy between our in vitro model and the in vivo situation
Fig. 8. Schematic representation of the interplay between pulmonary epithelial cells and neutrophils resulting in synergistic ROS production and inﬂammation. Upon LPS activation
via binding to TLR-4, pulmonary epithelial cells will produce large amounts of ROS that can activate the redox-sensitive transcription factors ERK1/2 and NF-κB. These activated
transcription factors will subsequently induce IL-8 production that can stimulate present neutrophils. Upon their stimulation, neutrophil NADPH oxidase will produce large
amounts of superoxide anion radicals that will further enhance the pro-inﬂammatory ROS-ERK1/2-NF-κB-IL-8 loop.
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including neutrophil elastase (NE) and protease 3 (PR3). Indeed, it
has been shown that both NE and PR3 are implicated in antimicrobial
defense by enhancing neutrophil-dependent inﬂammation and in-
ducing IL-8 production via epithelial signaling [58,59]. Moreover, a
protease-antiprotease imbalance in favor of the ﬁrst has been
suggested to play a role in the pathogenesis of various chronic lung
diseases including COPD and asthma [60,61]. However, the possible
interference of such proteases has been intercepted in our studies
by i) using the same batch of donors for all different experiments or
ii) applying murine neutrophils from animals with a genetically iden-
tical background except the knocking down of one subunit of NADPH
oxidase, which has not been linked to other biological functions or
pathways thus far. The role of these serine neutrophil proteases in
the observed crosstalk between lung epithelial cells and neutrophils
in vivo remains interesting and therefore worthwhile investigating.
Although the described synergism was observed in a relatively
basic method to investigate the interplay between pulmonary epi-
thelial cells and neutrophils, this model did enable us to investi-
gate the complete interaction between both cell types as it is also
occurring in vivo. The patho-physiological relevance of the per-
formed co-incubations exceeds that of single cell type models to
explore the effects of individual inﬂammatory and/or neutrophil-
derived components such as TNF-α and H2O2 respectively. The rel-
evance of our model can also be deducted from the fact that the
observed synergism in IL-8 release is only partly dependent of
NOX2. Moreover, the currently applied model may also be used
for the screening of potential inhibitors of this synergism such as
(dietary) antioxidants.
In conclusion, our ﬁndings strongly support the high impact of the
interplay between neutrophils and epithelial lung cells as well as the
key role of NOX-2 activity and IL-8 production in this crosstalk. Espe-
cially in patients suffering from chronic inﬂammatory lung diseaseshallmarked by inﬁltrated neutrophils, recurring exposure to LPS and
possibly other airborne pathogens may pose a signiﬁcantly increased
health hazard. Consequently, modulating the observed interplay by
using natural or synthetic NOX2 inhibitors might be a successful
new approach in the treatment of these diseases.
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